Alcon launches Centurion cataract surgery platform
The Centurion Vision System, a new phacoemulsification platform, will be available this year in nations in which it has received necessary regulatory approvals, Alcon announced in a press release.
“By combining multiple proprietary technologies and unique innovations as part of the Centurion Vision System, we are offering surgeons the next-generation phaco platform that will enable them to optimize every step of the cataract surgery,” Stephen Speares, Alcon’s Global Head of Cataract Franchise, said in the release.
The proprietary technologies at work in the system include:
- Active Fluidics, designed to remove the need to manually adjust fluid pressure and improve anterior chamber stability by maintaining a preset IOP during the procedure.
- Balanced Energy, designed to allow for reduced energy and increased efficiency and control during phacoemulsification.
- Applied Integration, which allows the system to be merged with other Alcon systems more easily for a broader suite.
Centurion also provides practitioners with an improved touch screen, a wireless footswitch and improved ergonomics, according to the release.
Alcon will continue rolling the system out in 2014 and plans to hold live demonstrations during the meetings of the European Society of Cataract and Refractive Surgeons and American Academy of Ophthalmology.